Splenomegaly
Information
- Disease name
- Splenomegaly
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02871219 | Active, not recruiting | Phase 2 | Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular Lymphoma | December 6, 2016 | July 23, 2024 |
| NCT00006148 | Completed | Spleen Size in Peripheral Blood Stem Cell Donors | August 2000 | June 2004 | |
| NCT04716166 | Completed | N/A | Incentive Spirometry and Upper Abdominal Laparoscopic Surgery | October 1, 2020 | May 30, 2021 |
| NCT01810419 | Completed | N/A | Ultrasound Estimation of Spleen Size | March 2013 | March 2014 |
| NCT01907932 | Completed | N/A | Estimation of Spleen by Residents With VScan | November 2013 | May 2014 |
| NCT01948076 | Completed | N/A | Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination | September 2012 | November 2012 |
| NCT04430881 | Completed | A National Study in Patients With Unexplained Splenomegaly | September 2015 | April 27, 2021 | |
| NCT02948283 | Completed | Phase 1 | Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia | September 5, 2017 | December 1, 2017 |
| NCT06345495 | Not yet recruiting | Phase 2 | High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly | September 30, 2024 | January 1, 2029 |
| NCT05641103 | Recruiting | PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD" | March 21, 2023 | December 31, 2025 | |
| NCT03801434 | Recruiting | Phase 2 | Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders | November 15, 2019 | November 30, 2025 |
| NCT02421354 | Terminated | Phase 2 | Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis | May 14, 2015 | April 13, 2018 |
| NCT02463669 | Terminated | The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department | April 2016 | October 4, 2020 | |
| NCT02730884 | Terminated | Phase 2 | Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia | August 16, 2017 | August 22, 2019 |
| NCT01201655 | Unknown status | Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis | January 2010 | December 2012 | |
| NCT02298634 | Withdrawn | Biomarker for Farber Disease (BioFarber) | August 20, 2018 | February 28, 2021 | |
| NCT01331642 | Withdrawn | Biomarker for Gaucher Disease: BioGaucher (BioGaucher) | August 20, 2018 | February 28, 2021 | |
| NCT02298699 | Withdrawn | Biomarker for Sly Disease (MPS VII) (BioSly) | August 20, 2018 | February 28, 2021 |
- HPO alt_id (Human Phenotype Ontology)
- HP:0001745
- HPO alt_id (Human Phenotype Ontology)
- HP:0006269
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001744
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013163